| Product Code: ETC7172308 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Fiji`s clinical oncology sector continued to rely on imports of next-generation sequencing technology, with top exporters being Australia, New Zealand, India, Bangladesh, and the USA. The market remained highly concentrated, indicating limited diversification in import sources. Despite a slight decline in growth rate from 2023 to 2024, the sector still saw a steady compound annual growth rate of 4.6% from 2020 to 2024. Fiji`s ongoing dependence on key exporting countries underscores the importance of strategic partnerships in meeting the country`s clinical oncology needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Clinical Oncology Next Generation Sequencing Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, 2022 & 2032F |
3.3 Fiji Clinical Oncology Next Generation Sequencing Market - Industry Life Cycle |
3.4 Fiji Clinical Oncology Next Generation Sequencing Market - Porter's Five Forces |
3.5 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.6 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Workflow, 2022 & 2032F |
3.7 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Fiji Clinical Oncology Next Generation Sequencing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Fiji |
4.2.2 Growing adoption of precision medicine in oncology |
4.2.3 Technological advancements in next generation sequencing for clinical oncology |
4.3 Market Restraints |
4.3.1 High costs associated with next generation sequencing |
4.3.2 Limited awareness and expertise in utilizing next generation sequencing in clinical oncology in Fiji |
5 Fiji Clinical Oncology Next Generation Sequencing Market Trends |
6 Fiji Clinical Oncology Next Generation Sequencing Market, By Types |
6.1 Fiji Clinical Oncology Next Generation Sequencing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Technology, 2022 - 2032F |
6.1.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Genome Sequencing, 2022 - 2032F |
6.1.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Whole Exome Sequencing, 2022 - 2032F |
6.1.5 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Targeted Sequencing, 2022 - 2032F |
6.1.6 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Resequencing, 2022 - 2032F |
6.2 Fiji Clinical Oncology Next Generation Sequencing Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Pre-Sequencing, 2022 - 2032F |
6.2.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Sequencing, 2022 - 2032F |
6.2.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By NGS Data Analysis, 2022 - 2032F |
6.3 Fiji Clinical Oncology Next Generation Sequencing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Screening, 2022 - 2032F |
6.3.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Companion Diagnostics, 2022 - 2032F |
6.3.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Fiji Clinical Oncology Next Generation Sequencing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.4.3 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.4.4 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Laboratories, 2022 - 2032F |
6.4.5 Fiji Clinical Oncology Next Generation Sequencing Market Revenues & Volume, By Others, 2022 - 2032F |
7 Fiji Clinical Oncology Next Generation Sequencing Market Import-Export Trade Statistics |
7.1 Fiji Clinical Oncology Next Generation Sequencing Market Export to Major Countries |
7.2 Fiji Clinical Oncology Next Generation Sequencing Market Imports from Major Countries |
8 Fiji Clinical Oncology Next Generation Sequencing Market Key Performance Indicators |
8.1 Average turnaround time for next generation sequencing tests |
8.2 Number of oncology centers offering next generation sequencing services |
8.3 Rate of adoption of next generation sequencing in clinical practice |
9 Fiji Clinical Oncology Next Generation Sequencing Market - Opportunity Assessment |
9.1 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.2 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Workflow, 2022 & 2032F |
9.3 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Fiji Clinical Oncology Next Generation Sequencing Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Fiji Clinical Oncology Next Generation Sequencing Market - Competitive Landscape |
10.1 Fiji Clinical Oncology Next Generation Sequencing Market Revenue Share, By Companies, 2025 |
10.2 Fiji Clinical Oncology Next Generation Sequencing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here